Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 4Phase 1/2 2Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia 3Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Respiratory Tract Diseases 1Rare Diseases 1Prostatic Neoplasms 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hormone Refractory Prostate Cancer 1Hemangioma 1Esophageal Stenosis Acquired 1Dendritic Cell Sarcoma, Interdigitating 1COVID-19 1Ataxia Telangiectasia 1Ataxia 1

Interventions

spartalizumab 1liposomal doxorubicin 1Salvia hispanica seed extract 1Rituximab 1Prednisone 1Methotrexate 1Gemcitabine 1Dexamethasone 1Clinical Protocols 1Cisplatin 1Cholecalciferol 1Azacitidine 1Asparaginase 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell × Prednisone × Clear all
NCT00161239 2009-12-11

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

Rutgers, The State University of New Jersey

Phase NA Terminated
64 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡